Home › Free Stock Grades › NAUT
Nautilus Biotechnolgy, Inc. (NAUT) Stock Grade
NAUT · Healthcare
C
Market Cap
$141.3M
P/E Ratio
—
Revenue Growth (YoY)
0.0%
Net Margin
0.0%
Return on Equity
—
Dividend Yield
None
About Nautilus Biotechnolgy, Inc.'s fundamentals
Nautilus Biotechnology has a market capitalization of $141.3 million and generated no year-over-year revenue growth in its latest period. The company reported a net loss in its most recent annual statement, resulting in a 0.0% net margin, and does not pay a dividend to shareholders. Traditional profitability metrics like P/E ratio and return on equity are not applicable given the company's loss-making status.